Technology Insights

COVID-19 research and innovation: 2021 open directory

Frances Wilkinson

Frances Wilkinson

Digital Content Officer

This ‘COVID-19 research and innovation 2021 open directory’ lists all the projects and opportunities we’ve received in response to our 2021 COVID-19 open call for research. Each of these projects has been submitted by an academic or research commercialisation professional with the aim of initiating meaningful conversations and partnerships leading to collaborative development and deployment of new pandemic interventions.

How to review the projects
A non-confidential summary of each project is hosted on IN-PART’s digital partnering platform for university-industry collaboration. Set up an account (it’s completely free), login, and follow the links below.

How to connect with the teams behind them
If you see a project that aligns with your R&D priorities, you can make a request for more information directly through the article on IN-PART. The academic team or project lead will then send you a response by email.

There are no costs or downstream fees for companies to use IN-PART’s matchmaking platform to connect with universities – it’s maintained by institutional subscriptions.

 

COVID-19 research and innovation 2021 open directory - IN-PART Blog - Banner 7

COVID-19 research and innovation 2021 open directory

Content navigation:

    1. Diagnostics
    2. Drug Discovery
    3. Modelling and Tracking
    4. PPE
    5. Therapeutics
    6. Vaccination

 

Diagnostics


Rapid and Ultrasensitive SARS-CoV-2 Antigen Detection for Acute COVID-19 Screening in Community Settings

University of Pennsylvania 
Read the project summary 

ORD Tech – Rapid Pathogen Testing
Oxford University Innovation
Read the project summary

Mass Antibody-Diagnosing Screen for COVID-19
University of Western Australia
Read the project summary

Antibody (IgG, IgA) Serology Test and Surrogate Neutralization Assay for SARS-CoV-2
Albert Einstein College of Medicine
Read the project summary

Novel Diagnostic Assay for the Detection of SARS-CoV-2 Variant Signatures
Innovate Calgary
Read the project summary 

Pooled Sample Testing Using Compressed Sensing for Increasing the Throughput and Reliability of Tests for the Detection of Defective Units in a Population
University of Iowa
Read the project summary 

Efficient Identification of Active Ingredients Against SARS-CoV-2 and Chemical Probes as Inhibitors of the 3CL and PL Proteases of Coronaviruses
TLB GmbH
Read the project summary 

ViralFx: Integrated Approach to the Diagnosis and Treatment of SARS-CoV-2
Sandia National Laboratories
Read the project summary 

Nucleocapsid protein for SARS-CoV-2 and other viruses
The University of Sheffield
Read the project summary 

SARS-CoV-2 Diagnostic Assay with Sensors of Immune Activation
The Ohio State University
Read the project summary (Added 24 MAY 2021)

 

COVID-19 research and innovation 2021 open directory - IN-PART Blog - Banner 1

Drug Discovery


Anti-viral Nasal Spray

University of Birmingham
Read the project summary

Evaluating GPR4 as a Therapeutic Target for COVID-19
East Carolina University
Read the project summary

RNA-based Degrader Approach to Suppress Pan Viral Replication
Mount Sinai Health System
Read the project summary

Tools for the Study of SARS-CoV-2 in BSL-2 Laboratories
University of Iowa
Read the project summary

 

COVID-19 research and innovation 2021 open directory - IN-PART Blog - Banner 2

Modelling and Tracking


A Longitudinal Study Measuring COVID-19 Infection Status and the Level of Anti-SARS-CoV-2 Antibodies in Staff and Clinical Trial Volunteers

Richmond Research Institute
Read the project summary

 

COVID-19 research and innovation 2021 open directory - IN-PART Blog - Banner 3

PPE


Vacuum Face Mask to Limit Dispersion of Potentially Infectious Droplets

University of Utah
Read the project summary

Configurable Face Shield to Protect Against Viral Infection
University of Iowa
Read the project summary

Device for Ultraviolet Light Sterilization of Face Masks and Other Items
Florida Atlantic University
Read the project summary (Added 02 JUNE 2021)

 

COVID-19 research and innovation 2021 open directory - IN-PART Blog - Banner 4

Therapeutics


Sub-20nM SARS CoV-2 Main Protease Non-covalent, Non-peptidic Remdesivir- Synergistic Inhibitors

Yale University
Read the project summary

Novel Inhibitors of SARS-CoV-2 PLpro
University of Arizona
Read the project summary 

A Broad-spectrum Antiviral for the Next Pandemic
Albert Einstein College of Medicine
Read the project summary

Early Therapeutic Interventions for CoViD-19 (Pharmacy Support Pack)
University of Huddersfield
Read the project summary

Broad-Spectrum Antiviral Materials
University of Manchester
Read the project summary (Added 24 MAY 2021)

Imaging and Novel Therapies for SARS-CoV-2 and Variants of Concern
Innovate Calgary
Read the project summary (Added 24 MAY 2021)

A Synthetic, Small Molecule for the Treatment of Enveloped Viruses like SARS-CoV-2
Virginia Commonwealth University
Read the project summary (Added 24 MAY 2021)

A Novel Therapeutic Platform for COVID-19
East Carolina University
Read the project summary (Added 24 MAY 2021)

Morus Alba Extract for Prevention and Treatment of COVID-19
University of Vienna
Read the project summary (Added 24 MAY 2021)

Treatment of Severe Covid19 Disease Using a Biological in Second Medical Use
Saarland University
Read the project summary (Added 24 MAY 2021)

PLpro Inhibitors Against SARS-CoV-2
University of Arizona
Read the project summary (Added 24 MAY 2021)

Novel Main Protease Inhibitors as SARS-CoV-2 Antivirals
University of Arizona
Read the project summary (Added 24 MAY 2021)

RIG-I RNA-based Immunotherapeutics
Oregon Health & Science University
Read the project summary (Added 02 JUNE 2021)

 

COVID-19 research and innovation 2021 open directory - IN-PART Blog - Banner 5

Vaccination


Population-scale SARS-CoV-2 Vaccine

Children’s Hospital of Philadelphia
Read the project summary

COVID Vaccine Storage at Room Temperatures
The University of North Carolina at Charlotte
Read the project summary

 

COVID-19 research and innovation 2021 open directory - IN-PART Blog - Banner 6

 

Additional COVID-19 research and innovation 2021 resources & content:

If you have any questions or want to speak with our team about our COVID-19 research and innovation directory, or any of the work we’re doing in response to COVID-19, feel free to send us a message at: alex@in-part.co.uk.

Copyrights reserved unless otherwise agreed – IN-PART Publishing Ltd., 2021: ‘COVID-19 research and innovation 2021 open directory

 


About IN-PART:

We believe brilliant connections can solve real-world problems. We match research pioneers from academia with decision-makers in industry sectors striving for a greater positive impact.
Our goal is to enable connections from around the world to match academic research with industry on a level playing field. Through our intelligent, matchmaking platform we showcase leading university innovations and connect academics with an international community of decision-makers in industry, creating meaningful dialogue and partnership.

IN-PART, a digital partnering platform for university-industry collaboration.
250+ universities and research institutes around the world currently showcase their research and innovation on IN-PART to find new collaboration partners in industry. R&D teams get free access to the platform (create an account here). There are no hidden costs and we don’t claim downstream success fees.

Discover, a bespoke scouting service for open innovation.
Through Discover, corporate R&D teams can leverage our extended academic network, which reaches multiple teams across 1,200+ universities and research institutes worldwide. In response to a specific research requirement or challenge, Discover enables R&D teams to identify new opportunities for commercialisation or to solicit proposals for new research.
Interested in speaking with our Discover team? Request a demo |  TTO or academic? Sign-up for weekly Discover emails.

 

COVID-19 research and innovation 2021 open directory - IN-PART Blog - Header

Image credits
Header: Timo Wielink/Unsplash License
Banners, in order of appearance: Testalize Me/Unsplash License, Volodymyr Hryshchenko/Unsplash License, Mufid Majnun/Unsplash License, Kobby Mendez/Unsplash License, CDC/Unsplash License, Hakan Nural/Unsplash License 

Insights View all

Insights into innovation, expertise, and technology developed by university researchers searching for industry partners through IN-PART